Stockreport

Viking Therapeutics: GLP-1/GIP Receptor Agonist And Its Competitive Landscape [Seeking Alpha]

Viking Therapeutics, Inc.  (VKTX) 
Last viking therapeutics, inc. earnings: 4/30 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.vikingtherapeutics.com
PDF 1 Like BioCGT Investor Follower s Follow Summary Viking Therapeutics' VK2735, a dual GLP-1/GIP receptor agonist, shows promising results in Phase II trials fo [Read more]